And, yes, it is noteworthy there are 3 male candidates for VP even though there are a large number of talented female scientists in RRS🤨 I am committed to increasing the # of female leaders in the Society and the field! 👍#HeforShe

#BioCommittee meets and greets at #ESTRO25 Great turnout. Welcome all biologists!

🔈 I am honored to be running alongside Sunil Krishnan & David Yu for Vice-President Elect of RRS 🙏🙏🙏 🧐You can find more info on the candidates here 👉 ftp.ameetingbydesign.com/ambddrop/202... Vote by May 1️⃣3️⃣ radres.org/Login.aspx @cvanpouillebox.bsky.social @profajchalmers.bsky.social

📢Insightful in press review on a lipid metabolic pathway + #radiotherapy response - a🔥area‼️ Also, a harbinger of more to come, more #radbio reviews in @ijrobp.bsky.social that is😊 Stay tuned😍 @cvanpouillebox.bsky.social @freddyeescorcia.bsky.social www.redjournal.org/article/S036...

🔥 #RadRes2025 Meeting #PuertoRico Sept 2025🌴🌞 Looking forward to: Symposium on Radiation Combination Therapies😍 Great to have @profajchalmers.bsky.social back‼️🙏 Though I will post about this meeting mostly on that other platform 🫠🤷‍♂️ x.com/HenningWille...

Immunogenomic cancer evolution: A framework to understand cancer immunosuppression www.science.org/doi/10.1126/...

Mass General Brigham to invest $400 million to open new cancer institute before Dana-Farber partnership ends www.bostonglobe.com/2025/03/18/b...

1/2 📢Abstract Submission is open for #RadRes2025 Sept 21-24 in #PuertoRico ‼️ (see ⬇️) There will be many oral presentations selected from abstracts🔥 Amazing scientific program, and I am especially excited about a strong immuno-oncology focus🙏 @cvanpouillebox.bsky.social @sandrademaria.bsky.social

ASTRO is accepting nominations for the 2025 ASTRO Mentorship Award. Nominations must be submitted by a colleague or mentee and are due by March 21. Learn more: ow.ly/1I6U50USy64

1/3 It is not too early to start thinking about the #RadRes2025 Meeting in #PuertoRico Sept 21-24, 2025 🌞🌴🍹🏖️ Abstract & Submission opens in 2 weeks‼️ The Program is shaping up to be FANTASTIC (link in 3rd post ⬇️)🔥🔥🔥 @cvanpouillebox.bsky.social (Who else is on BlueSky? (vs X, hard to recall)

Other than the brain, our immune system is the most complex part of the human body. For the first time, sequencing receptors of B and T cells, along w/ generative A.I., enabled diagnosis of medical conditions such as lupus. That's just for starters. erictopol.substack.com/p/the-first-...

If anyone is interested in following the NIH indirects case filed by Mass on behalf of 22 states, here is the link: www.courtlistener.com/docket/69625...

I am trying to write a grant about tumor metabolic diversity and cannot come up with a different term😂

Very bad news for cancer patients…

Tha=e #OncoAlertColloquium 🚨REGISTER for FREE HERE👉 https://buff.ly/4hKRVdM @rooogerthat of The Philippines Covering how to Treat #LungCancer when one does NOT have the Resources, Sing in to chat with Dr. Velasco The burden of disease of lung cancer remains high especially in Asia

“Opinion is the medium between knowledge and ignorance.” Plato (428 BC -347 BC)

The NIH overhead cut doesn't just hurt universities. It's deadly to the US economy. The US is a world leader in tech due to the ecosystem that NIH and NSF propel. It drives innovation for tech transfer, creates a highly-skilled sci/tech workforce, and fosters academic/industry crossfertilization.

University GCs are, I'm sure, talking about this or getting some rest (if they can) for a long battle ahead. I would suggest that we don't become armchair lawyers here. Let's focus on how to communicate the impact of implementing this on health, our communities, and the ability of the US to lead.

A Primer on Indirect Cost Rates

On changes to #NIH indirect rates, there is a law in place that prohibits NIH from making such changes without the approval of Congress. See Division D, Title II Section 224 of The Further Consolidated Appropriations Act, 2024 (Public Law No: 118-47) grants.nih.gov/grants/guide...

🔥Absolute pleasure to talk BRCAness/HRD as a predictor of chemoradiosensitivity in #breastcancer with the Simon Powell @mskcancercenter.bsky.social & Kerstin Borgmann UKE‼️ 🙏 to @sueyom.bsky.social @ijrobp.bsky.social My first #radbio podcast😊 🧵Tweetorial soon... (either here or on X, so torn 😂)

Higher NTCP with variable RBE predictions in Proton RT of brain tumours- especially for blindness and deppendent in Patient factors. LET or track-end optimization can lower the risk. @hzdr.bsky.social @oncoalert.bsky.social www.sciencedirect.com/science/arti...

Dang time flies ... Still have to convert last year's abstract into an actual manuscript 😅

Stay tuned for all things #lungcancer tomorrow!! Glad to be reviewing #radonc relevant advances🔥 in 2024 with my colleague Katie Keane, MD, tomorrow! REGISTER HERE: oncoalert.m-pages.com/rnaYzs/the-5...

wow! seems low tbh

New MGB Cancer Center building @massgeneralbrigham.bsky.social coming up pretty quickly‼️ But feels a long way (and a lot of traffic standstill) until 2️⃣0️⃣2️⃣7️⃣🙃

📢Thrilled to have started again our Annual Radiation Biology Lecture Series with robust attendance & all the radiation chemistry effects you need to know to understand #radiotherapy😊 ☢️🔬👩‍🔬 @massgeneralbrigham.bsky.social @harvard.edu @oncoalert.bsky.social #radbio

In the present discussions about NIH and the need for reform, two recurring points I am seeing are: (1) NIH doesn't fund truly high impact research (2) NIH needs to experiment with alternative approaches to peer review, particularly for high risk-high impact research 1/n

www.washingtonpost.com/business/202... Any more on what this means? NIH released exceptions for clinical trials from the prior order but now new reporting tonight behind the WaPo firewall that all federal grants and loans are being held… budget memo released today. #NIH #medsky #cansky

what a week🙄 #EndDryJanuary

#medphys #radonc 🥳Let's cheer each other up by sharing something good that happened in your clinic or Lab this week.... We got snow in Houston, and with my lab closed, I had distraction free research time. I made legit progress on my @astro-org.bsky.social abstract 😊💃💃💃😊

Some of this is normal-ish, some of it is unprecedented.

DM is doing a huge public service at the moment, tracking the changes at NIH as a result of Trump's executive orders. Also kudos to the Bluesky Science community, sharing their realtime experiences with delays and uncertainty.

NIH appears to have canceled/postponed all of its study sections—the independent review panels that approve federal grants for health research. Such grants fund the work/salaries of 300k people at more than 2,500 institutions

A new mechanism for cancer-induced immune evasion. We knew about cancer cells hijacking mitochondria. Now we learn about how their mitochondrial transfer to T cells impairs the tumor immune response. www.nature.com/articles/s41... www.nature.com/articles/d41...

Let's lighten up the overall mood a bit, shall we?🙃 👍https://x.com/SeanDreyer/status/1881841879601623145

📢Just out in @theaacr.bsky.social MCT We ventured into world of cancer metabolism❗️ 🔥These days @astro-org.bsky.social #radbio ➡️Targeting lipid synthesis for #radiotherapy ➡ Lots of variation across #lungcancer models ➡️Need biomarkers ➡️More soon‼️ NCI U01 Program🙏 aacrjournals.org/mct/article-...

Submissions for the 2025 ASTRO-AstraZeneca SCLC Therapy Challenge are now open! Learn more and submit your research proposal by April 30: www.astro.org/patient-care...

Cool paper in Cancer Discovery @theaacr.bsky.social from last week. My @mskdeptofmed.bsky.social colleague Charlie Rudin and MSK collaborators, led by Natasha Rekhtman, explore an unusual subset of small cell lung cancers that happen in people who never smoked cig aacrjournals.org/cancerdiscov....

Because crossposting on X + BlueSky is all the rage😂... Excited, & grateful🙏, to have my first ever #RedJournal Podcast in the👜 Also happened to be only the SECOND #RadBio Podcast ever❓Clearly we need to ⬆️ that😅 #RadBio4TheMasses Stay tuned‼️ 🙏 ➡️https://www.redjournal.org/multimedia/audio

Great advice on clinical trial design (with great reading list). Probably biggest take-home point: "Yes, you actually need a statistician"

Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma out on Science Advances https://buff.ly/4hgtu7P These findings reveal key distinctions in CART cytolytic behavior, which may inform the design of more effective therapies.

ASTRO requests feedback on the draft guideline on Radiation Therapy for WHO Grade 4 Diffuse Glioma (replacing the 2016 Glioblastoma Guideline). Submit comments through Monday, January 20. Learn more: ow.ly/XgHp50UG8HK

📢So much exciting #radbio in the new @ijrobp.bsky.social #RedJournal issue‼️ Oncology scan by @cvanpouillebox.bsky.social on the immunogenic properties of micronuclei🔥 www.redjournal.org/article/S036...

Ok fine, @cvanpouillebox.bsky.social convinced me to give this platform a try, because, Twitter/X, you know ... 😬